JP6437511B2 - High concentration magnesium ion concentrate - Google Patents

Description

The present invention relates to a high-concentration magnesium ion concentrate, a drinking water production system, and a drinking water production method .

  Water is important for the human body, and moderate hydration can improve human metabolism and inward circulation. With this increase in demand, related technologies are being developed.

For well-known drinking water technology, Patent Document 1 can be referred to. Patent Document 1 discloses, through a filter, a water purification tank in fluid communication with a purified water discharge tank including a drainage mechanism, a disinfectant storage partition, and A water purifier comprising a bactericide distribution box in fluid communication with a bactericide distribution port, wherein the water septic tank includes a water supply cup having an inlet and a mouth hole, the water supply cup comprising: Located at the upper end of the water septic tank and in fluid communication with the water septic tank through the hole, the apparatus further comprises a vertical pipe connecting the water supply cup and the disinfectant distribution box, When the vertical pipe is connected to the disinfectant distribution box, positive air pressure is generated, and when the vertical pipe is operated, the disinfectant is introduced into the water purification tank. Further, water purification method as described in Patent Document 2, first, Kyosui water into electric water purification device, then becomes the hardness of water in the electric water purification device, hardness levels ranging from 5~100ppm in CaCO ₃ meter Furthermore, in the electric water purifier , the alkalinity of the water is controlled so that the alkalinity of the CaCO ₃ meter is in the range of 10 to 100 ppm , and the water whose alkalinity is controlled and whose hardness is reduced is purified water. As a user.

  Traditionally, many technologies for producing potable water have focused on purifying substances that are harmful to the human body in the water, but what kind of water quality components have a positive impact on the human body There is room for improvement since no research has been conducted.

European Patent Publication No. 2298702 US Patent Specification No. 7,329,358

  The main object of the present invention is to solve the problem that the drinking water provided by the prior art cannot have a significant positive effect on the human body.

To solve the above object, a high concentration of magnesium ions concentrate according to the present invention, the weight percent 70000ppm and less magnesium ions over 60000Ppm, the following sodium ion weight percent 1000ppm or 3200 ppm, by weight percent 300ppm or 3000ppm and following potassium ions, you wherein the weight percent you include the following calcium ion 300ppm or 100 ppm.

The magnesium ion concentrator according to the present invention is a magnesium ion concentrator that produces a magnesium ion concentrate containing magnesium ions at a higher concentration than deep ocean water,
a. By passing microfiltration membrane, ultrafiltration membrane and reverse osmosis membrane in this order against deep ocean water, suspended matter of 0.025 μm to 10 μm and fine particles or bacteria of 5 nm to 10 nm and 0. A filtration unit for obtaining a first concentrated liquid from which a salt content of 2 nm to 1.0 nm is removed;
b. A vacuum low-temperature concentration unit for obtaining a second concentrated liquid by applying a pressure of 50 ° C. or higher and 70 ° C. or lower and 10 kPa or higher and 20 kPa or lower to the first concentrated liquid;
It is characterized by comprising.

In the above configuration,
c. Distillation in which the second concentrated liquid is heated at a temperature of 90 ° C. or higher and 120 ° C. or lower under normal pressure to precipitate a crystalline salt from the second concentrated liquid and obtain a supernatant as the third concentrated liquid. Means may be further provided.

Therefore, according to the magnesium ion-concentrating device according to the present invention, it is possible to produce drinking water containing magnesium ion abundance, according to the experiment, as compared by that component efficacy, a well-known technique, osteoporosis It has been found that it has the effect of improvement and anti-fatigue.

It is a schematic diagram which shows the mixing system of high magnesium content drinking water based on the Example of this invention. It is a schematic diagram which shows the bone density image represented by the micro computer tomography technique in the experiment example in the 1st Example, a control example, and a comparative example. It is a schematic diagram which shows the bone density image represented by the micro computer tomography technique in the experiment example in the 1st Example, a control example, and a comparative example. It is a schematic diagram which shows the bone density image represented by the micro computer tomography technique in the experiment example in the 1st Example, a control example, and a comparative example. It is a schematic diagram which shows the bone density image represented by the micro computer tomography technique in the experiment example in the 1st Example, a control example, and a comparative example. It is a schematic diagram which shows the bone density image represented by the micro computer tomography technique in the experiment example in the 1st Example, a control example, and a comparative example. It is a schematic diagram which shows the bone density image represented by the micro computer tomography technique in the experiment example in the 1st Example, a control example, and a comparative example. It is a schematic diagram which shows the trabecular image represented by the micro computer tomography technique in the experiment example in the 1st Example, a control example, and a comparative example. It is a schematic diagram which shows the trabecular image represented by the micro computer tomography technique in the experiment example in the 1st Example, a control example, and a comparative example. It is a schematic diagram which shows the trabecular image represented by the micro computer tomography technique in the experiment example in the 1st Example, a control example, and a comparative example. It is a schematic diagram which shows the trabecular image represented by the micro computer tomography technique in the experiment example in the 1st Example, a control example, and a comparative example. It is a schematic diagram which shows the trabecular image represented by the micro computer tomography technique in the experiment example in the 1st Example, a control example, and a comparative example. It is a schematic diagram which shows the trabecular image represented by the micro computer tomography technique in the experiment example in the 1st Example, a control example, and a comparative example. It is a figure which shows the improvement condition of the athletic ability when the experiment example in a 2nd Example and a control example ingest high-magnesium content drinking water and a placebo. It is a figure which shows the change of the amount of erythrocytes and total hemoglobin before the exercise | movement after the exercise example and control example in a 2nd Example, after intake of high magnesium content drinking water, and PLA, and 2 hours after exercise | movement. It is a figure which shows the change of the amount of erythrocytes and total hemoglobin before the exercise | movement after the exercise example and control example in a 2nd Example, after intake of high magnesium content drinking water, and PLA, and 2 hours after exercise | movement. It is a figure which shows the change of the amount of erythrocytes and total hemoglobin before the exercise | movement after the exercise example and control example in a 2nd Example, after intake of high magnesium content drinking water, and PLA, and 2 hours after exercise | movement. It is a figure which shows the change of the amount of erythrocytes and total hemoglobin before the exercise | movement after the exercise example and control example in a 2nd Example, after intake of high magnesium content drinking water, and PLA, and 2 hours after exercise | movement. It is a figure which shows the change of the amount of erythrocytes and total hemoglobin before the exercise | movement after the exercise example and control example in a 2nd Example, after intake of high magnesium content drinking water, and PLA, and 2 hours after exercise | movement. It is a figure which shows the change of the amount of erythrocytes and total hemoglobin before the exercise | movement after the exercise example and control example in a 2nd Example, after intake of high magnesium content drinking water, and PLA, and 2 hours after exercise | movement. It is a figure which shows the change of the amount of erythrocytes and total hemoglobin before the exercise | movement after the exercise example and control example in a 2nd Example, after intake of high magnesium content drinking water, and PLA, and 2 hours after exercise | movement. It is a figure which shows the change of the amount of erythrocytes and total hemoglobin before the exercise | movement after the exercise example and control example in a 2nd Example, after intake of high magnesium content drinking water, and PLA, and 2 hours after exercise | movement.

  Detailed description and technical contents of the present invention will be described with reference to the drawings.

The present invention, in a first embodiment, the following magnesium ions wt% or more 60000ppm 70000ppm, sodium ion weight percent of 1000ppm or 3200ppm or less, and less potassium ions weight percent 300ppm or 3000 ppm, weight percent 100ppm provides a high concentration of magnesium ions concentrate you encompass the following month Resid um ion 300ppm or more.

As shown in FIG. 1, which is a schematic diagram showing a mixing system for drinking water with a high magnesium content according to an embodiment of the present invention, the present invention includes a magnesium ion concentrating device 10, a purified water supply device 20, and a liquid mixture device 30. Comprehensive high magnesium content drinking water mixing system, wherein the magnesium ion concentrator 10 provides a high concentration magnesium ion concentrate as described above, and the purified water supply device 20 provides purified water, The liquid mixture device 30 communicates with the magnesium ion concentrating device 10 and the purified water supply device 20, and mixes the high concentration magnesium ion concentrated solution with the purified water to obtain high magnesium content drinking water.

In an embodiment of the present invention, the magnesium ion concentrator 10 can be either a high-concentration magnesium ion concentrate generator or a container that stores the high-concentration magnesium ion concentrate . If the magnesium ion concentrator 10 is the high-concentration magnesium ion concentrate generator, the high-concentration magnesium ion concentrate generator includes a filtration unit 11, a vacuum low-temperature concentration unit 12, and an atmospheric pressure as shown in FIG. A distillation unit 13 is included. Generation of the high concentration of magnesium ions concentrate is made by the high-concentration magnesium ions concentrate generator, and inclusive the following steps.

Step 1: In step 1, the filtering unit 11 by the by performing filtering with respect to deep ocean water, the following magnesium ions wt% or more 1900 ppm 3000 ppm, and the sodium weight percent is less than 21000ppm above 13000ppm ions, weight percent is obtained with the following potassium ion 1000ppm above 550 ppm, the first concentrate weight percent encompass the following calcium ion 1000ppm least 600 ppm. In the present embodiment, the deep sea water is deep water from below the sea surface having a depth of 200 m or more and 1500 m or less , and preferably, the deep water having a depth of 300 m or more and 700 m or less . Further, in this embodiment, the filtering unit 11, microfiltration membranes 11a, comprehensive ultrafiltration membrane 11b and reverse osmosis membrane 11c, for example, the microfiltration membrane 11a is, the less between 10μm or more 0.025μm By having the first pore diameter, the suspended matter such as mud, blue mushrooms, and microorganisms in the deep sea water is filtered, and the ultrafiltration membrane 11b has a second pore diameter of 5 nm or more and 10 nm or less . The fine particles and bacteria in the deep ocean water are filtered, and the reverse osmosis membrane 11c has a third pore diameter of 0.2 nm or more and 1.0 nm or less, thereby filtering the salinity in the deep ocean water. Yes.

Step 2: In step 2, said sodium by performing concentrated to the first concentrate, the weight percent 160000ppm and less magnesium ions than 10000 ppm, the weight percent of less 100000ppm or 60000ppm by the vacuum low concentration unit 12 an ion, by weight percent are obtained with the following potassium ion 6000ppm or 3000 ppm, the second concentrate weight percent encompass the following calcium ion 500ppm or 300 ppm. The vacuum cold enrichment unit 12 has a temperature of 50 ° C. or higher 70 ° C. or less, and a pressure of less than or 10 KPa 20 KPa.

Step 3: In step 3, the second concentrated liquid is heated by the atmospheric distillation unit 13 to precipitate a crystalline salt from the second concentrated liquid, and then the second concentrated liquid is allowed to stand. Thus, the third concentrated liquid is obtained by precipitating the crystalline salt at the bottom and pumping up the liquid at the top. In an embodiment of the present invention, the atmospheric distillation unit 13 gives a heating temperature of 90 ° C. or higher and 120 ° C. or lower to the second concentrated liquid.

Step 4: Step 4 is for cooling the third concentrated liquid, filtering the third concentrated liquid with a filter membrane 14 having a pore size of 0.2 μm or more and 2.0 μm or less , and removing impurities. The high concentration magnesium ion concentrate is obtained, and when the third concentrate passes through the filtration membrane 14, impurities are removed, but the concentration does not change, that is, the concentration of the third concentrate is , Equal to the high concentration magnesium ion concentrate . In the present invention, the high-concentration magnesium ions concentrate is a comprehensive two types of components, in the case of the first embodiment, the third concentrate, and 70000ppm following magnesium ions than 60000ppm weight percent, by weight percent encompasses the following sodium ion 1000ppm or 3200 ppm, and less potassium ions weight percent 300ppm or 3000 ppm, by weight percent and less calcium ions 300ppm or 100 ppm, the case of the second embodiment, the third concentrate , the following magnesium ions wt% or more 40000 ppm 50000 ppm, and the sodium ion weight percent is less than 18000ppm than 8000ppm, mosquitoes weight percent is less than 17000ppm than 8000ppm And um ion, weight percent encompasses the following calcium ion 15ppm or 250 ppm.

  The purified water supply device 20 can be either a purification device that obtains purified water by filtering water to be purified or a container that stores the purified water. If the purified water supply device 20 is the purification device, the purified water supply device 20 includes a first filtration cartridge 21, a low pressure switch 22, an inlet solenoid valve 23, a pressure increasing pump 24, and reverse osmosis as shown in FIG. Comprising a filtration cartridge 25, the first filtration cartridge 21 has a first inlet end 211 and a first outlet end 212 for receiving the purified water, and the low pressure switch 22 is connected to the first outlet end 212, the second inlet end 221 and the second outlet end 222 are connected to detect whether the water to be purified is continuously supplied to the first filtration cartridge 21, and the inlet solenoid valve 23. Has a third inlet end 231 and a third outlet end 232 connected to the second outlet end 222 to control the flow rate of the purified water, and the booster pump 24 A fourth inlet end 241 connected to the outlet end 232 and a fourth outlet end 242; in order to increase the flow rate of the water to be purified, a high-pressure pressing force is applied to the water to be purified; The cartridge 25 has a fifth inlet end 251 connected to the fourth outlet end 242 and a fifth outlet end 252 for supplying the purified water.

  The purified water supply device 20 further includes a washing electromagnetic valve 26, a purified water storage tank 27, a heating element 28 and a sterilizing element 29, and the washing electromagnetic valve 26 is connected to the sixth outlet end 253 of the reverse osmosis filtration cartridge 25. Thus, the washing flow rate for washing the reverse osmosis filtration cartridge 25 is controlled, the purified water storage tank 27 is installed between the reverse osmosis filtration cartridge 25 and the liquid mixture device 30, and the fifth outlet end 252 stores the purified water supplied, and the heating element 28 is installed between the reverse osmosis filtration cartridge 25 and the liquid mixture device 30 and heats the purified water to generate hot water, The hot water is supplied to the liquid mixture device 30, and the sterilization element 29 is installed between the reverse osmosis filtration cartridge 25 and the liquid mixture device 30, and for the purified water. And bacteria, to produce sterile water, and further supplies the sterile water to the mixture device 30.

The liquid mixture device 30 includes a liquid storage tank 31, a pumping pump 32, and a liquid mixture unit 33. The liquid storage tank 31 is used to store the concentrated magnesium ion concentrate, and the pumping pump 32 The concentrated magnesium ion concentrate is pumped from the liquid storage tank 31, and the mixed liquid unit 33 is configured to pump the purified water supplied from the fifth outlet end 252 and the high concentration pumped from the liquid storage tank 31 by the pumping pump 32. The magnesium ion concentrate is mixed to produce the high magnesium content potable water. Among them, the high magnesium content drinking water mixing system mixes the high concentration magnesium ion concentrate in drinking water having an appropriate hardness according to different drinking purposes and application ranges.

The high-concentration magnesium ion concentrate of the first embodiment described above can improve the user's osteoporosis problem, and the high-concentration magnesium ion concentrate of the second embodiment described above eliminates the problem of user fatigue. Can be improved. To specifically explain the effects of the high-concentration magnesium ion concentrate according to the first embodiment and the second embodiment of the present invention, please refer to the experimental examples and comparative examples performed based on the present invention described later. .

The high-concentration magnesium ion concentrate obtained in the first example simulates a menopause woman in a rat with an ovariectomy, and the menopause woman has a very rapid bone loss rate due to hormonal changes. Therefore, osteoporosis is likely to occur. The rats used in each of the experimental examples, control examples and comparative examples are female Sprague-Dawleys, which were first fed with different ratios of high magnesium content drinking water, and for each serum and tissue fragment. Analyzing.

The high-concentration magnesium ion concentrate dose fed to each experimental example, control example and comparative example is as shown in Table 1, and the unit of volume is per kilogram of body weight. The control example is a rat whose ovaries have not been excised. Among them, the purpose of administering calcium citrate is to clarify the effect of calcium on osteoporosis.

  Table 2 shows alkaline phosphatase (Alkaline phosphatase, ALP), serum urea nitrogen (Blood urea nitrogen, BUN), creatinine (creatineine) in the serum after feeding for the rats of each experimental example, control example and comparative example. , CRE), glutamate oxaloacetate transaminase (GOT), glutamate-pyruvate transaminase (GPT).

  Table 3 shows the measurement of calcium, magnesium, potassium, sodium, and phosphorus in the serum after feeding the rats of each experimental example, control example, and comparative example.

As can be seen from Table 2, after the ovaries were removed, the ALP increased from 115 (U / L) to 202 (U / L), which was a phenomenon reflecting osteoporosis. When the high-concentration magnesium ion concentrate obtained in the first embodiment of the present invention is drunk, ALP significantly decreases to 125 (U / L) or less, and is effective in improving osteoporosis. In addition, as can be seen from the results of BUN, CRE, GOT, and GPT, each experimental example does not affect the liver or kidney after drinking the high-concentration magnesium ion concentrate. As can be seen from 3, there was no adverse effect on the serum measured after feeding.

  In addition to the measurement of serum, the tissue fragments of each experimental example and comparative example were analyzed by micro computed tomography (Micro-computed tomography, Micro-CT) as shown in FIGS. 2A to 2F and FIGS. 3A to 3F. Bone density images and trabecular images are observed. FIGS. 2A to 2F are diagrams showing bone density images of Experimental Example 1, Experimental Example 2, Experimental Example 3, Control Example, Comparative Example 1, and Comparative Example 2, respectively. 3A to 3F show trabecular images of Experimental Example 1, Experimental Example 2, Experimental Example 3, Control Example, Comparative Example 1, and Comparative Example 2, respectively. As shown in FIGS. 2A to 2C, the bone mineral density of the control example and each experimental example is relatively high, and as shown in FIGS. 2E and 2F, the bone density of the comparative example is relatively decreased. ing. 3A to 3C, the trabecular bone of the control example and each experimental example is relatively fine, and the trabecular bone of the comparative example is relatively relatively small as can be seen in FIGS. 3E and 3F. It is bulky.

The high-concentration magnesium ion concentrate obtained in the second example has an exercise ability and exercise as shown in FIGS. 4 and 5A to 5G, respectively, when middle-aged men are used as experimental examples and young men are used as control examples. The amount of red blood cells (RBCs) before, during and after exercise is measured. FIG. 4 shows the improvement of exercise ability when the experimental example and the control example ingested a high concentration magnesium ion concentrate and placebo (PLA), and among them, the high concentration magnesium ion taken by the experimental example. The concentrate is high magnesium content drinking water with a hardness of 600. As can be seen from the figure, in the case of the control example, the exercise endurance ability after taking the high-concentration magnesium ion concentrate does not significantly improve and decreases by about 4.77%, whereas in the case of the experimental example The exercise endurance ability after taking the high-concentration magnesium ion concentrate has been remarkably improved, increasing by about 7.36%.

5A and 5C show the amount of red blood cells before exercise, after exercise, and 2 hours after exercise after ingesting the high magnesium content drinking water and PLA obtained by the control example and the experimental example in the second example. 5B and 5D show the area under the curve of FIGS. 5A and 5C, and FIGS. 5E and 5G show the control example and the experimental example in the second example. FIG. 5F and FIG. 5H show total hemoglobin (tHB) before exercise, after exercise, and 2 hours after exercise after ingesting the obtained high magnesium content drinking water and PLA. FIG. 5G shows the area under the curve (Area under the curve). As can be seen from the figure, in the case of the control example, taking the high concentration magnesium ion concentrate and PLA has little effect on RBCs and tHB, but in the case of the experimental example, the high concentration magnesium ion concentrate was taken. RBCs and tHB are clearly increased. Further examination of experimental examples shows that the cause of the decrease in RBCs after exercise in those who took PLA was due to hemolysis induced after exercise (Hemolysis), This inhibits oxygen transport and suppresses RBC-mediated vasorelaxation, which has an adverse effect on exercise capacity, and the tendency of tHB is similar to RBCs. Therefore, from this result, it can be inferred that the high-concentration magnesium ion concentrate obtained in the second embodiment can reduce the hemolytic reaction induced after exercise, improving the exercise endurance ability of middle-aged men doing.

From the above, the component range of the high concentration magnesium ion concentrate selected according to the present invention is:
Through experiments, it was found that the high-concentration magnesium ion concentrate has an effect of improving osteoporosis and anti-fatigue.

10 Magnesium Ion Concentrator 11 Filtration Unit 11a Microfiltration Membrane 11b Ultrafiltration Membrane 11c Reverse Osmosis Membrane 12 Vacuum Low Temperature Concentration Unit 13 Atmospheric Distillation Unit 14 Filtration Membrane 20 Purified Water Supply Device 21 First Filtration Cartridge 211 First Inlet End 212 First One outlet end 22 Low pressure switch 221 Second inlet end 222 Second outlet end 23 Inlet solenoid valve 231 Third inlet end 232 Third outlet end 24 Booster pump 241 Fourth inlet end 242 Fourth outlet end 25 Reverse osmosis filtration cartridge 251 Fifth inlet end 252 Fifth outlet end 253 Sixth outlet end 26 Washing electromagnetic valve 27 Purified water storage tank 28 Heating element 29 Sterilizing element 30 Liquid mixture device 31 Liquid storage tank 32 Pumping pump 33 Liquid mixture unit

Claims (1)

  Includes magnesium ions having a weight percent of 60000 ppm to 70000 ppm, sodium ions having a weight percent of 1000 ppm to 3200 ppm, potassium ions having a weight percent of 300 ppm to 3000 ppm, and calcium ions having a weight percent of 100 ppm to 300 ppm A high-concentration magnesium ion concentrate characterized by that.